Veracyte Inc. Stock
Your prediction
Veracyte Inc. Stock
Veracyte Inc. gained 0.540% compared to yesterday.
So far the community has only identified positive things for Veracyte Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Veracyte Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Veracyte Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Veracyte Inc. | 0.540% | -8.824% | 2.762% | -8.824% | -2.618% | 43.132% | -19.130% |
| Ardelyx Inc. | 0.740% | 2.185% | 3.441% | 0.960% | 1.712% | 197.935% | -3.034% |
| Krystal Biotech | 0.300% | 10.715% | 18.830% | 17.200% | 34.757% | 188.873% | - |
| Evolus Inc | -1.690% | 3.571% | -4.132% | -48.673% | -44.762% | -17.143% | 95.616% |
News
Veracyte (VCYT) Q2 Revenue Jumps 14%
Veracyte (NASDAQ:VCYT), a leader in advanced cancer diagnostics, reported results for Q2 2025 on August 6, 2025. The headline news: the company outperformed expectations on both revenue and
